ENPAC LIMITED

Company number 07497539 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ENPAC LIMITED — Financial Health Assessment

Companies House Number: 07497539 Industry: Wholesale of other intermediate products (SIC 46760) Assessment Date: Based on accounts for year ended 31 March 2026


1. Financial Health Score: D

Grade Justification: The company is exhibiting clear symptoms of balance sheet insolvency, with liabilities exceeding assets for three consecutive years. However, the patient is not on life support — there is a visible recovery trajectory, with net liabilities narrowing significantly from £109,482 (2024) to £19,827 (2026). The trend is encouraging, but the company remains in a financially precarious condition requiring close monitoring and corrective action. A grade of D reflects a business that is unwell but responding to treatment.


2. Key Vital Signs

Balance Sheet Position (Net Assets / Shareholders' Funds)

Year Ending Net Assets (£) Trend
March 2022 +119,774 Healthy
March 2023 +21,390 Declining
March 2024 -109,482 Critical
March 2025 -35,737 Recovering
March 2026 -19,827 Improving

Interpretation: Like a patient whose vital signs crashed in 2024, the company suffered a dramatic haemorrhage of shareholder value — falling from a positive net asset position of £119,774 in 2022 to negative £109,482 in just two years. This suggests either significant trading losses, write-downs, or a substantial increase in creditor obligations during that period. The last two years show the "patient" is stabilising, with net liabilities reduced by approximately £90,000 over two years.

Working Capital (Net Current Assets)

Metric 2026 (£) 2025 (£)
Current Assets 203,897 208,367
Current Liabilities (229,726) (251,607)
Net Current Assets (25,829) (43,240)

Interpretation: The company has negative working capital, meaning short-term obligations exceed short-term assets. This is the financial equivalent of shortness of breath — the business may struggle to meet its immediate obligations as they fall due. However, the improvement from £-43,240 to £-25,829 indicates the breathing difficulties are easing.

Total Assets and Liabilities

Year Total Assets (£) Total Liabilities (£)
2022 291,572 171,798
2023 242,453 221,063
2024 158,268 267,750
2025 215,870 251,607
2026 209,899 229,726

Interpretation: Total assets peaked in 2022 and contracted sharply through 2024, before partially recovering. Liabilities peaked in 2024 at £267,750 and have been steadily reduced. The gap between assets and liabilities is closing, but the company still owes more than it owns.

Fixed Assets

Year Fixed Assets (£)
2026 6,002
2025 7,503

Interpretation: Minimal fixed asset base, consistent with a wholesale distribution business that likely operates from leased premises and carries inventory rather than heavy equipment. The slight decline reflects normal depreciation.

Cash Position

Cash data is only available for earlier years (£8,346 in 2022 and £5,884 in 2021), suggesting a thin cash buffer. Given the current asset base of £203,897 in 2026 is largely comprised of stock and debtors, cash reserves are likely to remain tight — analogous to a patient with low reserves fighting off infection.

Capital Structure

  • Share Capital: £1.00 (nominal)
  • PSC: name shown to subscribers owns more than 75% of shares
  • Directors: name shown to subscribers and name shown to subscribers (family-run business)

Interpretation: A tightly held family company with minimal share capital. The entire equity buffer has been built through retained profits (P&L reserve), which has now been eroded into negative territory. The directors' personal exposure to the business's financial health is significant.


3. Diagnosis

Primary Condition: Balance Sheet Insolvency with Recovery Underway

The company is technically insolvent on a balance sheet basis — its total liabilities (£229,726) exceed its total assets (£209,899), resulting in negative shareholders' funds of £19,827. In medical terms, this is a chronic condition that has developed over several years but is showing signs of responding to treatment.

Underlying Causes (Inferred)

The dramatic deterioration between 2022 and 2024 — where net assets fell from +£119,774 to -£109,482, a swing of approximately £229,000 — points to one or more of the following:

  1. Significant trading losses during 2023 and 2024, potentially linked to external economic pressures (inflation, supply chain disruption, energy costs) affecting the wholesale sector
  2. Inventory write-downs or bad debts that eroded asset values
  3. Increased creditor balances as the business may have deferred payments during a difficult trading period

Positive Symptoms

  • Liability reduction: Total liabilities have decreased by approximately £38,000 from the 2024 peak, suggesting active debt management
  • Asset stabilisation: Total assets have held steady at around £210,000–£216,000 for two years, indicating the business has found a stable operating level
  • Filing compliance: Accounts and confirmation statements are filed on time — the directors are meeting their statutory obligations, suggesting they remain engaged with the business
  • Continuity: The company has been trading for over 15 years (incorporated January 2011) and has maintained a consistent workforce of 3 employees

Concerning Symptoms

  • Negative working capital persists, creating ongoing liquidity risk
  • Negative equity means the company owes more than it owns — if creditors demanded immediate payment, the business could not cover its obligations from asset realisation
  • No income statement data is available (the directors have elected not to include it, as permitted under the micro-entity regime), making it difficult to assess whether the recovery is driven by trading profitability or other factors such as director loans or asset revaluations
  • Thin cash reserves (based on historical data) increase vulnerability to short-term shocks

4. Prognosis

Short-Term Outlook (12 months): Cautiously Stable

The company appears to have arrested its decline and is gradually repairing its balance sheet. If the current rate of recovery continues — approximately £45,000 reduction in net liabilities per year over the last two years — the company could return to positive net asset territory within 6–12 months. However, this assumes no external shocks and continued trading stability.

Key Risks

  • Creditor pressure: With negative working capital, the business is vulnerable if any major creditor tightens payment terms or demands settlement
  • Economic sensitivity: As a wholesale intermediary, the business is exposed to both upstream supply chain pressures and downstream customer demand fluctuations
  • Limited financial buffer: The absence of significant cash reserves or positive equity means there is little room for error

5. Recommendations

Immediate Actions (0–3 months)

  1. Prepare a detailed cash flow forecast: Given the negative working capital, understanding weekly and monthly cash movements is critical. Identify any creditor payment pinch points in the next 90 days.

  2. Engage with key creditors: Proactive communication with major suppliers can prevent unexpected payment demands. Consider negotiating extended payment terms where relationships are strong.

  3. Review debtor collections: With current assets of £203,897 (likely including significant trade debtors), accelerating collections could provide immediate liquidity relief. Consider offering early settlement discounts to key customers.

Short-Term Actions (3–12 months)

  1. Target positive working capital: The gap is £25,829. A combination of debtor reduction, inventory optimisation, and controlled creditor management could close this within a year.

  2. Conduct a profitability review: Since no income statement is filed, the directors should internally analyse gross margins by product line, identify loss-making activities, and focus resources on the most profitable segments of the wholesale portfolio.

  3. Consider director support: If the directors are willing and able, a director's loan could accelerate the return to positive net assets, providing additional financial cushion and signalling confidence to external stakeholders.

Medium-Term Actions (12–24 months)

  1. Rebuild equity buffer: Once net assets return to positive territory, aim to build a minimum reserve of 3–6 months of operating costs to provide resilience against future economic shocks.

  2. Diversify supplier and customer base: Reduce concentration risk by ensuring no single supplier or customer represents an excessive proportion of purchases or sales.

  3. Review business model viability: Given the sharp decline in 2023–2024, assess whether the current wholesale model is sustainable or whether adjustments to product mix, pricing, or market focus are needed.


Names of the people mentioned are shown to subscribers. See subscription

Perspective: Financial Health Diagnostician · Model: glm-5.2 · Generated 21 October 2026